Last updated: December 18, 2024
Sponsor: University of Aberdeen
Overall Status: Active - Recruiting
Phase
N/A
Condition
Heart Disease
Congestive Heart Failure
Circulation Disorders
Treatment
Blood collection for genetic analysis
Clinical Study ID
NCT04513054
2-025-18
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
All patients who have been diagnosed with Takotsubo cardiomyopathy in Scotlandbetween 2010 to date.
Familial cases elsewhere in the world who would be willing to participate.
Exclusion
Exclusion Criteria:
- Unwillingness to participate
Study Design
Total Participants: 700
Treatment Group(s): 1
Primary Treatment: Blood collection for genetic analysis
Phase:
Study Start date:
March 12, 2019
Estimated Completion Date:
December 31, 2028
Study Description
Connect with a study center
Cardiovascular Research Facility
Aberdeen, Aberdeenshire AB25 2ZD
United KingdomActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.